Evidence map›Paper›PMID 42490761›Full record

ArticleAngewandte Chemie (International ed. in English)2026

Exclusive Hydroformylation of Terminal Olefins: A Phosphorus-Free Ruthenium System for the Selective Functionalization of Complex Mixtures.

Mohamed Niyaz Vellala Syed Ali, Ida Ziccarelli, Dilver Peña Fuentes, Christoph Kubis, Robert Franke, Ralf Jackstell, Matthias Beller

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mohamed Niyaz Vellala Syed AliDepartment of Applied Homogeneous Catalysis, Leibniz-Institut für Katalyse e. V., Albert-Einstein-Straße 29a, Rostock, Germany.ORCID https://orcid.org/0000-0003-1039-7593
Ida ZiccarelliLaboratory of Industrial and Synthetic Organic Chemistry (LISOC), Department of Chemistry and Chemical Technologies, University of Calabria, Arcavacata di Rende, Cosenza, Italy.ORCID https://orcid.org/0000-0003-3591-0787
Dilver Peña FuentesDepartment of Applied Homogeneous Catalysis, Leibniz-Institut für Katalyse e. V., Albert-Einstein-Straße 29a, Rostock, Germany.
Christoph KubisDepartment of Applied Homogeneous Catalysis, Leibniz-Institut für Katalyse e. V., Albert-Einstein-Straße 29a, Rostock, Germany.
Robert FrankeEvonik Oxeno GmbH, Paul-Baumann-Straße. 1, Marl, Germany.
Ralf JackstellDepartment of Applied Homogeneous Catalysis, Leibniz-Institut für Katalyse e. V., Albert-Einstein-Straße 29a, Rostock, Germany.
Matthias BellerDepartment of Applied Homogeneous Catalysis, Leibniz-Institut für Katalyse e. V., Albert-Einstein-Straße 29a, Rostock, Germany.ORCID https://orcid.org/0000-0001-5709-0965

Funding

BMBF FKZ: 03XP0609CEvonik Oxeno GmbH
6 · The paper itself

Abstract

We report a paradigm shift in ruthenium-catalyzed hydroformylation using a remarkably simple, phosphorus-free system based on ruthenium carbonyl complexes and DBU (1,8-diazabicyclo[5.4.0]undec-7-ene). The optimal catalytic system operates under mild conditions and exhibits an unprecedented "terminal-only" selectivity. It quantitatively discriminates between terminal and internal or multi-substituted double bonds, which has been a long-standing challenge in oxo synthesis. Traditional systems often trigger the isomerization of internal olefins, but our catalyst leaves them untouched, even within complex industrial feedstocks. Comprehensive mechanistic investigations, including in situ IR spectroscopy and high-pressure VT NMR spectroscopy, identify the tetranuclear ruthenium-hydride cluster [DBUH]

Indexed as

chemo‐ and regioselective hydroformylationDBU as a ligandphosphor‐free ruthenium catalystruthenium‐hydride intermediateselective terminal olefin functionalization

Identifiers

PMID42490761
PMCPMC13592321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.